Stockscreener 앱 받기
2.50
1.01%
0.02
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Organogenesis Amnuvx Gets FDA Review for Knee OA - AllSci
FDA accepts Organogenesis’ application for knee osteoarthritis treatment - Investing.com
Organogenesis' Biologics License Application for ReNu Accepted by FDA for Review - Moomoo
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis - The Manila Times
Organogenesis wins FDA review for ReNu, a knee osteoarthritis treatment - Stock Titan
Enterprise value to revenue forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView
Price to book forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView
Organogenesis | 10-K: FY2025 Annual Report - Moomoo
Enterprise value to EBITDA forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView
Price to earnings forward of Organogenesis Holdings Inc. – NASDAQ:ORGO - TradingView
Organogenesis Holdings Inc.(NasdaqCM:ORGO) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Price to earnings forward of Organogenesis Holdings, Inc. Class A – LSX:A2PA31 - TradingView
Organogenesis Holdings Inc.(NasdaqCM:ORGO) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Organogenesis Holdings Inc.(NasdaqCM: ORGO) added to Russell 2000 Value Benchmark - marketscreener.com
Organogenesis Holdings Inc.(NasdaqCM:ORGO) added to Russell Microcap Value Benchmark Index - marketscreener.com
Enterprise value to EBIT forward of Organogenesis Holdings, Inc. Class A – LSX:A2PA31 - TradingView
Organogenesis Holdings Inc.(NasdaqCM:ORGO) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Organogenesis Holdings Inc.(NasdaqCM:ORGO) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Organogenesis Holdings Inc.(NasdaqCM:ORGO) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Organogenesis Holdings Inc.(NasdaqCM:ORGO) added to Russell 3000E Value Benchmark - marketscreener.com
Organogenesis Holdings, Inc. Class A Actuals & Estimates (NASDAQ:ORGO) - TradingView
ORGO Forecast — Price Target — Prediction for 2027 - TradingView
Organogenesis Holdings Inc (ORGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Organogenesis Holdings (ORGO) Edges Higher as Shares Approach Key ResistanceVolume Breadth - dars.gov.et
Organogenesis Holdings Inc (ORGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Organogenesis Holdings Inc (ORGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Spotlight On 3 Promising Penny Stocks With At Least $200M Market Cap - simplywall.st
Organogenesis Holdings Inc (ORGO) Institutional Confidence - TradingKey
Organogenesis Holdings Inc (ORGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Organogenesis Holdings Inc (ORGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Organogenesis Holdings Inc - TradingKey
Organogenesis Holdings Inc (ORGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Organogenesis Holdings Inc (ORGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Organogenesis re-elects Garrett Lustig to its board - TradingView
Organogenesis (NASDAQ: ORGO) investors reelect full board and approve pay - Stock Titan
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It - GlobeNewswire
Organogenesis: Mesmerized By Wound Care Struggles, Upcoming ReNu Blockbuster Overlooked - Seeking Alpha
ORGO Q1 2026 Earnings: Significant EPS Miss Highlights Persistent ChallengesGuidance Downgrade Alert - dars.gov.et
ORGO Q1 2026 Earnings: EPS Misses Estimates by 29.66% as Losses WidenNegative Surprise Momentum - newsline.com
Organogenesis Holdings (ORGO) Consolidates Near Support After Marginal DeclineVolatility Skew - newsline.com
The Body as Blueprint - lifehealth.com
Organogenesis Holdings (ORGO) Slides 1.65% as It Tests Key Support at $2.26KAMA Signal - Město Břeclav
Organogenesis plans rolling BLA submission for ReNu by year-end - Investing.com
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts - Newswire Canada
Number of shareholders of Organogenesis Holdings, Inc. Class A – DUS:2PQ - TradingView
Organogenesis shares jump 20% following positive clinical trial results - MSN
Organogenesis Holdings Faces Selling Pressure as ORGO Slips to $2.57Oversold Bounce Ideas - newsline.com
Organogenesis Holdings (ORGO) Declines 1.5% as Stock Tests Key Support ZoneFund Manager Survey - The Legal Advocate
Truist initiates Organogenesis stock at Hold on reimbursement shifts - Investing.com UK
Truist initiates Organogenesis stock at Hold on reimbursement shifts By Investing.com - Investing.com India
Truist Initiates Organogenesis Holdings at Hold With $3 Price Target - marketscreener.com
ORGO stock rallies after hours on clearing regulatory pathway for pain relief treatment - MSN
ORGOOrganogenesis Holdings Inc Stock Price and Quote - Finviz
- The Legal Advocate
Organogenesis Holdings (ORGO) Edges Lower as Stock Hovers Near Key SupportBullish Percent Index - The Legal Advocate
Organogenesis rises as PuraPlyAM succeeds in diabetic foot ulcers - MSN
0.17%
1.78%
자본화:
|
볼륨(24시간):